Business Wire
Precision BioSciences Receives U.S. FDA Clearance of Investigational New Drug Application for First-in-Class PBGENE-DMD for Treatment of Duchenne Muscular Dystrophy
📈
AI Sentiment
Highly Positive
9/10
Precision BioSciences Inc. News
Latest updates and market news for DTIL
1 news
Feb 11 - Feb 17, 2026
Page 1
Share this news page